You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tuberous sclerosis complex (TSC)

Showing 1 - 25 of 9,011
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TSC, Behavioral Symptoms Trial in Carrboro, Cincinnati (Behavioral Intervention in a small group platform)

Recruiting
  • TSC
  • Behavioral Symptoms
  • Behavioral Intervention in a small group platform
  • Carrboro, North Carolina
  • +1 more
Oct 23, 2023

Tuberous Sclerosis Complex Trial in United States (Ganaxolone)

Enrolling by invitation
  • Tuberous Sclerosis Complex
  • Phoenix, Arizona
  • +13 more
Jan 24, 2023

Renal Angiomyolipoma Trial (Everolimus)

Not yet recruiting
  • Renal Angiomyolipoma
  • (no location specified)
Aug 15, 2022

Tuberous Sclerosis Complex Trial in Lodz, Warsaw (Rapamycin, Placebo)

Not yet recruiting
  • Tuberous Sclerosis Complex
  • Rapamycin
  • Placebo
  • Lodz, Poland
  • +1 more
Sep 6, 2022

Tuberous Sclerosis, Lymphangioleiomyomatosis Trial in Canada, United States (procedure, genetic, other)

Recruiting
  • Tuberous Sclerosis
  • Lymphangioleiomyomatosis
  • Phlebotomy
  • +3 more
  • Birmingham, Alabama
  • +22 more
Jan 6, 2023

Facial Angiofibroma, Tuberous Sclerosis Trial in Worldwide (rapamycin, )

Completed
  • Facial Angiofibroma
  • Tuberous Sclerosis
  • Phoenix, Arizona
  • +16 more
Jul 26, 2022

Tuberous Sclerosis Complex Trial in Japan (NPC-12Y gel, NPC-12Y gel)

Recruiting
  • Tuberous Sclerosis Complex
  • NPC-12Y gel
  • NPC-12Y placebo gel
  • Toyoake, Aichi, Japan
  • +4 more
Aug 8, 2022

Tuberous Sclerosis Complex, Epilepsy Trial in United States (Sirolimus, Placebo)

Recruiting
  • Tuberous Sclerosis Complex
  • Epilepsy
  • Birmingham, Alabama
  • +7 more
Sep 2, 2022

Autism Spectrum Disorder and Intellectual Disability

Recruiting
  • Tuberous Sclerosis
  • +2 more
    • Birmingham, Alabama
    • +5 more
    Jul 29, 2021

    Tuberous Sclerosis Complex, Epilepsy Trial in Cincinnati (TAVT-18 (sirolimus))

    Active, not recruiting
    • Tuberous Sclerosis Complex
    • Epilepsy
    • TAVT-18 (sirolimus)
    • Cincinnati, Ohio
      Cincinnati Children's Hospital
    Jan 10, 2022

    Autism in Infants With Tuberous Sclerosis Complex (TSC)

    Completed
    • Tuberous Sclerosis Complex
      • Birmingham, Alabama
      • +4 more
      Feb 2, 2021

      Tuberous Sclerosis Trial in United States (Ganaxolone)

      Completed
      • Tuberous Sclerosis
      • Los Angeles, California
      • +6 more
      Oct 27, 2022

      Tuberous Sclerosis Complex Trial in United States (Vigabatrin, Placebo)

      Active, not recruiting
      • Tuberous Sclerosis Complex
      • Birmingham, Alabama
      • +12 more
      May 4, 2022

      Tuberous Sclerosis Trial in United States (GNX oral suspension, TID, Placebo)

      Recruiting
      • Tuberous Sclerosis
      • GNX oral suspension, TID
      • Placebo
      • Phoenix, Arizona
      • +36 more
      Oct 28, 2022

      Studies in Patients With Tuberous Sclerosis Complex

      Recruiting
      • Tuberous Sclerosis Complex
        • Phoenix, Arizona
          Translational Genomics Research Institute (TGen)
        Oct 18, 2022

        Epilepsy, Tuberous Sclerosis Complex, Focal Cortical Dysplasia Trial in New York (Everolimus)

        Completed
        Has Results
        • Epilepsy
        • +2 more
        • New York, New York
          New York University Langone Medical Center
        Aug 31, 2021

        Tuberous Sclerosis Complex Trial in Bristol (Acceptance and Commitment Therapy (ACT))

        Recruiting
        • Tuberous Sclerosis Complex
        • Acceptance and Commitment Therapy (ACT)
        • Bristol, United Kingdom
          University Hospitals Bristol and Weston NHS Trust
        May 10, 2023

        Tuberous Sclerosis Complex Associated Neuropsychiatric Disease Trial in United Kingdom, United States (Cannabidiol Oral Solution

        Not yet recruiting
        • Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
        • Cannabidiol Oral Solution [Epidiolex]
        • Los Angeles, California
        • +6 more
        May 9, 2023

        Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Philadelphia (Simvastatin, Sirolimus Oral Product, Everolimus Oral

        Completed
        Has Results
        • Lymphangioleiomyomatosis
        • Tuberous Sclerosis Complex
        • Philadelphia, Pennsylvania
          University of Pennsylvania
        Aug 12, 2020

        Tuberous Sclerosis Complex, Self-injury, Autism Trial in Baltimore (Sirolimus, Everolimus)

        Completed
        Has Results
        • Tuberous Sclerosis Complex
        • +2 more
        • Baltimore, Maryland
          Kennedy Krieger Institute
        Mar 26, 2021

        Tuberous Sclerosis Complex Trial in United States (Basimglurant with crossover to Placebo, Placebo with crossover to

        Recruiting
        • Tuberous Sclerosis Complex
        • Basimglurant with crossover to Placebo
        • Placebo with crossover to Basimglurant
        • Phoenix, Arizona
        • +47 more
        Jan 3, 2023

        Lymphangioleiomyomatosis, Tuberous Sclerosis Complex Trial in Boston ([11C]acetate)

        Recruiting
        • Lymphangioleiomyomatosis
        • Tuberous Sclerosis Complex
        • Boston, Massachusetts
          Brigham and Women's Hospital
        Jul 20, 2022

        Tuberous Sclerosis Complex, Aspirin, Epilepsy Trial in Beijing (Aspirin, AED, Placebo)

        Unknown status
        • Tuberous Sclerosis Complex
        • +4 more
        • Beijing, Beijing, China
          Department of Neurology, Peking Union Medical College Hospital
        Jun 5, 2020

        Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)

        Active, not recruiting
        • Hypomelanotic Macules
        • +8 more
          • Tirana, Albania
          • +7 more
          Mar 23, 2022

          Tuberous Sclerosis Complex, Seizures Trial in Boston (GWP42003-P)

          Completed
          Has Results
          • Tuberous Sclerosis Complex
          • Seizures
          • Boston, Massachusetts
            Massachusetts General Hospital
          Jul 12, 2022